Legacy Capital Group California’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,418
Closed -$268K – 326
2026
Q1
$268K Sell
1,418
-8,315
-85% -$1.75M 0.1% 253
2025
Q4
$1.93M Buy
9,733
+1,532
+19% +$310K 0.47% 43
2025
Q3
$1.67M Sell
8,201
-72
-0.9% -$12.8K 0.42% 47
2025
Q2
$1.46M Buy
+8,273
New +$1.25M 0.4% 49
2024
Q4
– Sell
-6,350
Closed -$1.06M – 357
2024
Q3
$1.06M Buy
+6,350
New +$960K 0.35% 64

Other funds holding THC

Legacy Capital Group California's THC Position: Q2 2026 in Review

Legacy Capital Group California sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,418 shares — an estimated $268K sold.

Legacy Capital Group California first reported a position in THC in Q3 2024 and held it in 5 quarters. The position peaked at $1.93M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Legacy Capital Group California reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Legacy Capital Group California sold 1,418 Tenet Healthcare shares in Q2 2026, an estimated $268K.
  • Legacy Capital Group California first reported a position in Tenet Healthcare in Q3 2024 and held it in 5 quarters.
  • Legacy Capital Group California's Tenet Healthcare position peaked at $1.93M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.